As of May 2026 Theravance Biopharma has a market cap of โน80.75 Billion. This makes Theravance Biopharma the world's 6389th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On May 18th, 2026 the market cap of Theravance Biopharma was reported to be: